PMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL

British Journal of Cancer

Volumn 73, Issue 9, 1996, Pages 1044-1048

  Adema, G J ^a   Bakker, A B H ^a   De Boer, A J ^a   Hohenstein, P ^a   Figdor, C G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytotoxic T cell; gp100 pMel17; Melanoma; NKI beteb

Indexed keywords

COMPLEMENTARY DNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HMB 45; TUMOR ANTIGEN;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; MALIGNANT LENTIGO; MELANOCYTE; MELANOMA; NONHUMAN; PRIORITY JOURNAL;

EID: 0029926876     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.202     Document Type: Article

References (26)

1. ADEMA GJ, DE BOER AJ, VAN 'T HULLENAAR R, DENIJN M, RUITER DJ, VOGEL AM AND FIGDOR CG. (1993). Melanocyte lineage-specific antigens recognised by monoclonal antibodies NKI-beteb, HMB-50 and HMB-45 are encoded by a single cDNA. Am. J. Pathol., 143, 1579-1585.
2. ADEMA GJ, DE BOER AJ, VOGEL AM, LOENEN WAM AND FIGDOR CG. (1994). Molecular characterisation of the melanocyte lineage specific antigen gp100. J. Biol. Chem., 269, 20126-20133.
3. BAKKER ABH, SCHREURS MWJ, DE BOER AJ, KAWAKAMI Y, ROSENBERG SA, ADEMA GJ AND FIGDOR CG. (1994). Melanocyte lineage-specific antigen gp100 is recognised by melanoma-derived tumour-infiltrating lymphocytes. J. Exp. Med., 179, 1005-1009.
4. BAKKER ABH, SCHREURS MWJ, TAFAZZUL G, DE BOER AJ, KAWAKAMI Y, ADEMA GJ AND FIGDOR CG. (1995). Identification of a novel peptide derived from the melanocyte specific gp100 antigen as the dominant epitope recognised by an HLA-A2.1 restricted anti-melanoma CTL line. Int. J. Cancer, 62, 97-102.
5. BRICHARD V, VAN PEL A, WÖLFEL T, WÖLFEL C, DE PLAEN E, LETHÉ B, COULIE P AND BOON T. (1993). The tyrosinase gene codes for an antigen recognised by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 178, 489-495.
6. COULIE PG, BRICHARD V, VAN PEL A, WÖLFEL T, SCHNEIDER J, TRAVERSARI C, MATTEI S, DE PLAEN E, LURQUIN C, SZIKORA J-P, RENAULD J-C AND BOON T. (1994). A new gene coding for a differentiation antigen recognised by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 180, 35-42.
7. COX AL, SKIPPER J, CHEN Y, HENDERSON RA, DARROW TL, SHABANOWITZ J, ENGELHARD VH, HUNT DF AND SLINGLUFF CA. (1994). Identification of a peptide recognised by five melanoma-specific human cytotoxic T cell lines. Science, 264, 716-719.
8. DEL VAL M, SCHLICHT HJ, RUPPERT T, REDDEHASE MJ AND KOSZINOWSKI UH. (1991). Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighbouring residues in the protein. Cell, 66, 1145-1153.
9. DRIJFHOUT WJ, BRANDT RMP, D'AMARO J, KAST WM AND MELIEF CJM. (1995). Detailed motifs for peptides binding to HLA-A2.1 derived from large random sets of peptides using a cellular binding assay. Hum. Immunol., 43, 1-12.
10. EISENLOHR LC, YEWDELL JW AND BENNINK JR. (1992). Flanking sequences influence the presentation of an endogenously synthesised peptide to cytotoxic T lymphocytes. J. Exp. Med., 175, 481-487.
11. FALK K, RÖTZSCHKE O, STEVANOVIC S, JUNG G AND RAMMENSEE H-G. (1991). Allele specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature, 351, 290-296.
12. GAUGLER B, VAN DEN EYNDE B, VAN DER BRUGGEN P, ROMERO P, GAFORIO JJ, DE PLAEN E, LETHÉ B, BRASSEUR F AND BOON T. (1994). Human gene MAGE-3 codes for an antigen recognised on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med., 179, 921-930.
13. KAWAKAMI Y, ZAKUT R, TOPALIAN SL, STOTTER H AND ROSENBERG SA. (1992). Shared human melanoma antigens. Recognition by tumour-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. J. Immunol., 148, 638-643.
14. KAWAKAMI Y, ELIYAHU S, DELGADO CH, ROBBINS PF, RIVOLTINI L, TOPALIAN SL, MIKI T AND ROSENBERG SA. (1994a). Cloning of the gene coding for a shared human melanoma antigen recognised by autologous T cells infiltrating into tumour. Proc. Natl Acad. Sci. USA, 91, 3515-3519.
15. KAWAKAMI Y, ELIYAHU S, DELGADO CH, ROBBINS PF, SAKAGUCHI K, APPELLA E, YANNELLI JR, ADEMA GJ, MIKI T AND ROSENBERG SA. (1994b). Identification of a human melanoma antigen recognised by tumour-infiltrating lymphocytes associated with in vivo tumour rejection. Proc. Natl Acad. Sci. USA, 91, 6458-6462.
16. KAWAKAMI Y, ELIYAHU S, JENNINGS C, SAKAGUCHI K, KANG X, SOUTHWOOD S, ROBBINS PF, SETTE A, APPELLA E AND ROSENBERG SA. (1995). Recognition of multiple epitopes in the human melanoma antigen gp100 by tumour infiltrating T-lymphocyes associated with in vivo tumour regression. J. Immunol., 154, 3961-3968.
17. KNUTH A, WÖLFEL T AND MEYER ZUM BÜSCHENFELDE K-H. (1992). T cell responses to human malignant tumours. Cancer Surv., 13, 39-52.
18. KWON BS, CHINTAMMANENI C, KOZAK CA, COPELAND NG, GILBERT DJ, JENKINS N, BARTON D, FRANCKE U, KOBAYASHI Y AND KIM K. (1991). A melanocyte-specific gene, pMel17, maps near the silver coat colour locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12. Proc. Natl Acad. Sci. USA, 88, 9228-9232.
19. MATTES MJ, THOMSON TM, OLD LJ AND LLOYD KO. (1983). A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum. Int. J. Cancer, 32, 717-721.
20. RUITER DJ. (1990). Melanomas and other skin neoplasms. Pathology and case reports. Curr. Opin. Oncol., 2, 377-387.
21. SHILYANSKI J, NISHIMURA MI, YANELLI JR, KAWAKAMI Y, JACKNIN LS, CHARMLY P AND ROSENBERG SA. (1994). T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumour-infiltrating lymphocytes. Proc. Natl Acad. Sci. USA, 91, 2829-2833.
22. VAN DER BRUGGEN P, TRAVERSARI C, CHOMEZ P, LURQUIN C, DE PLAEN E, VAN DEN EYNDE B, KNUTH A AND BOON T. (1991). A gene encoding an antigen recognised by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643-1647.
23. VENNEGOOR C, HAGEMAN P, VAN NOUHUIJS H, RUITER DJ, CALAFAT J, RINGENS PJ AND RÜMKE P. (1988). A monoclonal antibody specific for cells of the melanocytic lineage. Am. J. Pathol., 130, 179-192.
24. VIJAYASARADHI S, BOUCHARD B AND HOUGHTON AN. (1990). The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product. J. Exp. Med., 171, 1375-1380.
25. VOGEL AM AND ESCLAMADO RM. (1988). Identification of a secreted Mr 95.000 glycoprotein in human melanocytes and melanomas by a melanocyte specific antibody. Cancer Res., 48, 1286-1294.
26. WANG RF, ROBBINS PF, KAWAKAMI Y, KANG XQ AND ROSENBERG SA. (1995). Identification of a gene encoding a melanoma tumour antigen recognised by HLA-A31-restricted tumour infiltrating lymphocytes. J. Exp Med., 181, 799-804.